Stay updated on Risdiplam in SMA Infants Clinical Trial

Sign up to get notified when there's something new on the Risdiplam in SMA Infants Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risdiplam in SMA Infants Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.
    Difference
    0.9%
    Check dated 2025-07-04T01:24:21.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025, and the revision number has changed from v2.16.2 to v2.16.4.
    Difference
    2%
    Check dated 2025-06-19T17:24:28.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T07:44:02.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T05:27:59.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T19:39:01.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The webpage has removed detailed information about a global study of oral risdiplam for spinal muscular atrophy (SMA) in pre-symptomatic infants, including study design, inclusion and exclusion criteria, and treatment duration, while adding a new registry identifier and a revision number.
    Difference
    24%
    Check dated 2025-04-16T13:31:04.000Z thumbnail image

Stay in the know with updates to Risdiplam in SMA Infants Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Infants Clinical Trial page.